» Authors » Fuming Qiu

Fuming Qiu

Explore the profile of Fuming Qiu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 37
Citations 1323
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhou B, Chen M, Hao Z, Li L, Zhang Y, Fang B, et al.
J Nanobiotechnology . 2025 Feb; 23(1):137. PMID: 39994712
Triple-negative breast cancer (TNBC) is characterized by high rates of metastasis and recurrence, along with a low sensitivity to immunotherapy, resulting in a paucity of effective therapeutic strategies. Herein, we...
2.
Xu B, Zhang Q, Luo Y, Tong Z, Sun T, Shan C, et al.
Nat Commun . 2025 Jan; 16(1):716. PMID: 39820749
Lerociclib (GB491), a highly selective oral CDK4/6 inhibitor, has displayed anti-tumor activity and differentiated safety and tolerability profile in previous ph1/2 clinical trials. The LEONARDA-1, a randomized, double-blind, phase III...
3.
Zhao J, Huang F, Xu X, Zhang Y, Xing X, Huang J, et al.
Front Oncol . 2024 Dec; 14:1444431. PMID: 39664178
Breast cancer (BC) remains a leading cause of cancer-related mortality in women, with hormone receptor-positive (HR+) tumors accounting for a significant proportion of cases. Despite advancements in endocrine therapy (ET),...
4.
Zhang L, Pan J, Wang M, Yang J, Zhu S, Li L, et al.
Adv Sci (Weinh) . 2024 Dec; 12(4):e2310266. PMID: 39630109
Chronic stress can significantly promote breast cancer progression. When exposed to chronic stress, exosomes released from neural and neuroendocrine cells in the central nervous system are enhanced and modified. However,...
5.
Wang J, Tong Z, Tan Y, Shi Y, Wu Y, Zhou Q, et al.
Cell Rep Med . 2024 Aug; 5(9):101707. PMID: 39216478
This phase 1a study assesses ESG401 in patients with heavily pretreated locally advanced or metastatic solid tumors, focusing on metastatic breast cancer. Forty patients are enrolled: three experience dose-limiting toxicities,...
6.
Wu D, Guo S, Zhang B, Huang F, Qian W, Qiu F, et al.
Diagnostics (Basel) . 2024 Apr; 14(7). PMID: 38611678
Bone metastasis has been reported in up to 70% of patients with advanced breast cancer. A total of 55.76% of skeletal metastases in women were derived from breast cancer. However,...
7.
Zhang X, Shao M, Yao J, Zhao L, Li L, Chen M, et al.
Future Oncol . 2024 Feb; 20(3):121-129. PMID: 38353107
Immune checkpoint inhibitors (ICIs) plus chemotherapy has demonstrated efficacy in resectable non-small-cell lung cancer (NSCLC), yet the optimal period of neoadjuvant immunochemotherapy is undetermined. In a phase II study (neoSCORE,...
8.
Wang Y, Qin H, Cai Y, Chen X, Li H, Montoya-Durango D, et al.
iScience . 2023 May; 26(5):106630. PMID: 37192973
Natural IL-17-producing γδ T cells (γδT17 cells) are unconventional innate-like T cells that undergo functional programming in the fetal thymus. However, the intrinsic metabolic mechanisms of γδT17 cell development remain...
9.
Shao M, Yao J, Wang Y, Zhao L, Li B, Li L, et al.
Signal Transduct Target Ther . 2023 Apr; 8(1):146. PMID: 37032401
No abstract available.
10.
Wang Y, Qiu F, Yan J
Trends Cancer . 2022 Dec; 9(4):265-269. PMID: 36564282
In innate immune cells, the transcription factor cellular musculoaponeurotic fibrosarcoma (c-Maf) influences cell fate and function through molecular and metabolic programming, thereby influencing immune homeostasis and antitumor immunity. We discuss...